Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126215152 | 12621515 | 2 | F | 20160127 | 20160825 | 20160804 | 20160831 | EXP | US-CELGENEUS-USA-2016020163 | CELGENE | 62.90 | YR | M | Y | 116.68000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126215152 | 12621515 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | U | U | 115027 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 126215152 | 12621515 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | 1500 MILLIGRAM | U | U | 115027 | 100 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 126215152 | 12621515 | 3 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | U | U | 115027 | 75 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 126215152 | 12621515 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | U | 55974 | 1000 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 126215152 | 12621515 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | U | 55974 | 800 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 126215152 | 12621515 | 6 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | U | 55974 | 600 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 126215152 | 12621515 | 7 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 0 | 10 | MG | TABLETS | QD | |||||||
| 126215152 | 12621515 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 325 | MG | TABLETS | QD | |||||||
| 126215152 | 12621515 | 9 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | 0 | 24000 | IU | CAPSULES | BID | |||||||
| 126215152 | 12621515 | 10 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 0 | 100 | MG | CAPSULES | BID | |||||||
| 126215152 | 12621515 | 11 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Oral | 0 | 160 | MG | TABLETS | QD | |||||||
| 126215152 | 12621515 | 12 | C | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 50 | UG | TABLETS | QD | |||||||
| 126215152 | 12621515 | 13 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MILLIGRAM | 0 | 20 | MG | TABLETS | QD | ||||||
| 126215152 | 12621515 | 14 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 325 MILLIGRAM | 0 | 25 | MG | TABLETS | BID | ||||||
| 126215152 | 12621515 | 15 | C | NAPROXEN. | NAPROXEN | 1 | Oral | 48000 IU (INTERNATIONAL UNIT) | 0 | 500 | MG | TABLETS | TID | ||||||
| 126215152 | 12621515 | 16 | C | Ondansetron HCl | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 200 MILLIGRAM | 0 | 8 | MG | TABLETS | Q12H | ||||||
| 126215152 | 12621515 | 17 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | Oral | 160 MILLIGRAM | 0 | 5 | MG | TABLETS | |||||||
| 126215152 | 12621515 | 18 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | Oral | 50 MICROGRAM | 0 | 40 | MG | SUSTAINED-RELEASE TABLET | QD | ||||||
| 126215152 | 12621515 | 19 | C | SERTRALINE HCL | SERTRALINE HYDROCHLORIDE | 1 | Oral | 20 MILLIGRAM | 0 | 100 | MG | TABLETS | QD | ||||||
| 126215152 | 12621515 | 20 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 50 MILLIGRAM | 0 | 40 | MG | TABLETS | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126215152 | 12621515 | 1 | Adenocarcinoma pancreas |
| 126215152 | 12621515 | 4 | Adenocarcinoma pancreas |
| 126215152 | 12621515 | 7 | Product used for unknown indication |
| 126215152 | 12621515 | 8 | Product used for unknown indication |
| 126215152 | 12621515 | 9 | Product used for unknown indication |
| 126215152 | 12621515 | 10 | Constipation |
| 126215152 | 12621515 | 11 | Product used for unknown indication |
| 126215152 | 12621515 | 12 | Product used for unknown indication |
| 126215152 | 12621515 | 13 | Blood pressure measurement |
| 126215152 | 12621515 | 14 | Product used for unknown indication |
| 126215152 | 12621515 | 15 | Product used for unknown indication |
| 126215152 | 12621515 | 16 | Product used for unknown indication |
| 126215152 | 12621515 | 17 | Pain |
| 126215152 | 12621515 | 18 | Pain |
| 126215152 | 12621515 | 19 | Product used for unknown indication |
| 126215152 | 12621515 | 20 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126215152 | 12621515 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126215152 | 12621515 | Abdominal pain | |
| 126215152 | 12621515 | Atrial fibrillation | |
| 126215152 | 12621515 | Dehydration | |
| 126215152 | 12621515 | Dizziness | |
| 126215152 | 12621515 | Dyspnoea | |
| 126215152 | 12621515 | Oedema peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126215152 | 12621515 | 1 | 20151026 | 0 | ||
| 126215152 | 12621515 | 2 | 20160119 | 0 | ||
| 126215152 | 12621515 | 3 | 20160208 | 0 | ||
| 126215152 | 12621515 | 4 | 20151026 | 0 | ||
| 126215152 | 12621515 | 5 | 20160119 | 0 | ||
| 126215152 | 12621515 | 6 | 20160208 | 0 | ||
| 126215152 | 12621515 | 8 | 20151109 | 0 | ||
| 126215152 | 12621515 | 9 | 20151020 | 0 | ||
| 126215152 | 12621515 | 10 | 20151005 | 0 | ||
| 126215152 | 12621515 | 11 | 20151005 | 0 | ||
| 126215152 | 12621515 | 12 | 20151005 | 0 | ||
| 126215152 | 12621515 | 15 | 20151019 | 0 | ||
| 126215152 | 12621515 | 16 | 20151026 | 0 | ||
| 126215152 | 12621515 | 18 | 20151005 | 0 | ||
| 126215152 | 12621515 | 19 | 20151005 | 0 | ||
| 126215152 | 12621515 | 20 | 20151005 | 0 |